Trends and regional differences in testosterone prescribing in Australia, 1991–2001
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To analyse temporal trends and geographical variations in testosterone prescribing in Australia. DESIGN AND SETTING: An analysis of testosterone prescribing over the past 11 years according to products and region, determined by Pharmaceutical Benefits Scheme (PBS) expenditure in Australian states and territories. MAIN OUTCOME MEASURE: Patterns of monthly PBS expenditure on injectable, oral and implantable testosterone products from 1 January 1991 to 30 December 2001, classified by state or territory. RESULTS: There were two periods (1993-1994 and 1998-1999) of striking upsurge followed by declines in national total prescribing of testosterone. These changes were more prominent for oral than injectable testosterone products, and patterns were similar in all regions, apart from a disproportionately higher peak in Western Australia in 1998. On a per-capita basis, Western Australia showed a dramatic increase in prescribing of oral and implantable, but not injectable, testosterone coinciding with the opening of a franchised men's sexual health clinic in Perth. CONCLUSION: The two striking upsurges in testosterone prescribing despite no convincing new evidence to justify them appear to reflect promotional activity to prescribe testosterone for older men, rather than overcoming the underdiagnosis of androgen deficiency related to pituitary or testicular disease in younger men. The curtailments after the introduced restrictions to PBS prescribing for older men without overt androgen deficiency were partial and temporary, suggesting that such regulatory barriers are only partly successful in counteracting the commercial and populist pressure driving excessive testosterone prescribing. Professional and community education is needed for appropriate diagnosis of genuine androgen deficiency in younger men, while discouraging unproven testosterone treatment for ageing men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study
Bojesen, A., Juul, S., & Gravholt, C. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021491 · Cited by 894
Testosterone supplementation therapy for older men: potential benefits and risks
Gruenewald, D. A., & Matsumoto, A. M. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1601-5215.2002.51018.x · Cited by 279
Cited by
Meier, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.2 · Cited by 274
“The median (range) serum testosterone level for quartile 1 was 227 (3-291) ng/dL; for quartile 2, 343 (294-398) ng/dL; for quartile 3, 473 (401-559) ng/dL; and for quartile 4, 646 (559-1519) ng/dL.”
BackgroundSex Steroids and All-Cause and Cause-Specific Mortality in Men
Araujo, A. B. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1252 · Cited by 272
Handelsman, D. J. (2013) · Medical Journal of Australia · doi:10.5694/mja13.10111 · Cited by 253
Self-citationCorrelates of low testosterone and symptomatic androgen deficiency in a population-based sample
Hall, S. A., Esche, G. R., Araujo, A. B., Travison, T. G., Clark, R. V., Williams, R. E., & McKinlay, J. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0021 · Cited by 167
“Available data suggest sales of prescription testosterone are on the rise (35), despite debate over the appropriateness of its use (36, 37) and the absence of changes in approved indications for testosterone treatment (38).”
BackgroundMale late-onset hypogonadism: pathogenesis, diagnosis and treatment
Huhtaniemi, I., & Forti, G. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.47 · Cited by 88
Metadata
- Authors
- Handelsman, D. J.
- Venue
- Medical Journal of Australia
- Publisher
- AMPCo
- Published
- 2004-10
- Volume
- 181
- Issue
- 8
- Pages
- 419-422
- ISSN
- 0025-729X (ISSN-L)
- 1326-5377
- OpenAlex
- W2184810891
- Cited by
- 48
- References
- 2
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trends and regional differences in testosterone prescribing in Australia, 1991–2001. https://app.cochat.ai/papers/10.5694/j.1326-5377.2004.tb06364.x
- The paper
- Handelsman, D. J. (2004). Trends and regional differences in testosterone prescribing in Australia, 1991–2001. Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2004.tb06364.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.